FLNA Earnings FILANA THERAPEUTICS, INC.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Net income
ROE
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–27 of 27
| Q4 2025 (derived) | 2025-12-31 | -0.26 | 2026-03-12 | 10-K |
| FY 2025 | 2025-12-31 | -1.88 | 2026-03-12 | 10-K |
| Q3 2025 | 2025-09-30 | -0.22 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.92 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.48 | 2025-05-08 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -0.58 | 2025-03-03 | 10-K |
| FY 2024 | 2024-12-31 | -1.46 | 2025-03-03 | 10-K |
| Q3 2024 | 2024-09-30 | -0.58 | 2024-11-07 | 10-Q |
| Q2 2024 | 2024-06-30 | 0.13 | 2024-08-08 | 10-Q |
| Q1 2024 | 2024-03-31 | -0.43 | 2024-05-10 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -0.50 | — | — |
| FY 2023 | 2023-12-31 | -2.32 | — | — |
| Q3 2023 | 2023-09-30 | -0.61 | — | — |
| Q2 2023 | 2023-06-30 | -0.63 | 2023-08-03 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.58 | 2023-05-01 | 10-Q |
| FY 2022 | 2022-12-31 | -1.90 | — | — |
| Q2 2022 | 2022-06-30 | -0.48 | — | — |
| Q1 2022 | 2022-03-31 | -0.44 | — | — |
| FY 2015 | 2015-12-31 | -0.31 | 2016-03-03 | 10-K |
| FY 2014 | 2014-12-31 | -0.27 | 2015-02-18 | 10-K |
| Q4 2013 | 2013-12-31 | 0.72 | 2014-02-05 | 10-K |
| FY 2013 | 2013-12-31 | 0.70 | 2014-02-05 | 10-K |
| Q3 2013 | 2013-09-30 | -0.02 | — | — |
| Q2 2013 | 2013-06-30 | -0.01 | — | — |
| Q1 2013 | 2013-03-31 | -0.01 | — | — |
| FY 2012 | 2012-12-31 | -0.08 | — | — |
| FY 2011 | 2011-12-31 | -0.06 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.